BST2 and T-cell non-Hodgkin lymphoma: In addition, we examined the expression of CD317 by IHC in 52 T-cell lymphomas (TCL) samples and 8 normal lymphoid samples, and found that CD317 protein was markedly elevated in the TCL samples (Fig. 1C).